| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |